Evommune, Inc. · BX:EVMN
Evommune, Inc. shareholders
As of Sep 30, 2026, 101 institutions reported holding Evommune, Inc., 81.0% of its shares. Largest: EQT Fund Management S.a r.l., Ra Capital Management, L.P. and Point72 Asset Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Evommune, Inc. | Change | Filed |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.29M | 12.8% | no change | Nov 12, 2026 |
| Ra Capital Management, L.P. | 3.49M | 8.5% | no change | Nov 16, 2026 |
| Point72 Asset Management, L.P. | 2.43M | 5.9% | +999K | Nov 16, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.93M | 4.7% | no change | Nov 13, 2026 |
| Nan Fung Group Holdings Ltd | 1.44M | 3.5% | no change | Nov 13, 2026 |
| Defilade Capital Management, L.P. | 1.43M | 3.5% | +637K | Nov 16, 2026 |
| Vanguard | 1.3M | 3.1% | +208K | Nov 13, 2026 |
| Vestal Point Capital, LP | 1.25M | 3.0% | +250K | Nov 16, 2026 |
| Baker Bros. Advisors LP | 1.23M | 3.0% | +387K | Nov 16, 2026 |
| Kynam Capital Management, LP | 1.2M | 2.9% | new | Nov 16, 2026 |